RecruitingNot ApplicableNCT05911243

Feasibility of Auricular Acupressure for Appetite and Weight in Patients With Stage II-IV Gastric, Esophageal, and Pancreatic Cancer

A Randomized Controlled Trial Testing the Effects of an Acupressure Intervention on Appetite and Weight in Patients With Gastric, Esophageal, and Pancreatic Cancer: A Pilot and Feasibility Study


Sponsor

University of Washington

Enrollment

66 participants

Start Date

Jul 22, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This clinical trial evaluates the feasibility and acceptability of acupressure to the ear (auricular) to address appetite and weight in patients with stage II-IV gastric, esophageal, or pancreatic cancer. Cancer anorexia, the abnormal loss of appetite, directly leads to cancer-associated weight loss (cachexia) through malnourishment, reduced caloric intake, treatment side-effects, and other modifiable risk factors. Cachexia prolongs length of hospital stay for patients, negatively impacts treatment tolerance and adherence, and reduces overall patient quality of life. Auricular acupressure is a form of micro-acupuncture that exerts its effect by stimulating the central nervous system using adhesive taped pellets applied to specific locations on the external ear. The use of these pellets to deliver auricular acupressure has been shown to improve pain, fatigue, insomnia, nausea and vomiting, depression, and quality of life in both cancer and non-cancer settings. Auricular acupressure is a safe, inexpensive, and non-invasive approach to addressing cancer-related symptoms and treatment side-effects and may be effective at improving appetite and weight loss in stage II-IV gastric, esophageal, and pancreatic cancer patients.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study is testing ear acupressure — small seeds taped to specific points on the ear — to see if it can help improve appetite and reduce weight loss in people with stomach, esophageal, or pancreatic cancer. **You may be eligible if...** - You are 18–65 years old - You have stage II–IV gastric, esophageal, or pancreatic cancer - You have reduced appetite (score of 70 or less out of 100) - You are scheduled for at least 60 more days of cancer treatment - You have access to a phone and electronic device **You may NOT be eligible if...** - Your appetite score is above 70 (relatively good appetite) - You are not continuing systemic treatment for cancer Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREAcupressure Therapy

Undergo auricular acupressure

OTHERBest Practice

Receive usual care

PROCEDUREBiospecimen Collection

Undergo collection of blood samples

OTHERQuestionnaire Administration

Ancillary studies


Locations(1)

Fred Hutch/University of Washington Cancer Consortium

Seattle, Washington, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05911243


Related Trials